Search results
WHO COVID vaccine advisers recommend switch to JN.1 strain
Center for Infectious Disease Research and Policy· 8 hours agoThe World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition, which...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks· 21 hours agoPfizer’s top-line numbers in the first quarter of 2024 will include revenues from the acquisition of Seagen, which closed in mid-December 2023. The acquisition added Seagen’s antibody ...
Blood test might someday diagnose early MS
Medical Xpress· 3 days agoIn one in 10 cases of MS, the body begins producing a distinctive set of antibodies in the blood years before symptoms start appearing, researchers...
Q&A on Reducing COVID-19 Risk for Elderly, Immunocompromised - FactCheck.org
FactCheck.org· 6 days agoThe updated COVID-19 vaccines and, in some cases, a new monoclonal antibody can provide increased protection for this group. “At this point, many people have had multiple ...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 4 days agoThis was the first research project conducted to evaluate the immunity induced by the...
Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Clinical Trials Arena via Yahoo Finance· 18 hours agoSirexatamab acts by inhibiting dickkopf-1 (Dkk-1). The monoclonal antibody (mAb) is under...
BIOSECURE bill targets more Chinese companies as biotechs and their customers adapt to defunding
Pharmaceutical Technology via Yahoo Finance· 11 hours agoUS lawmakers have added more Chinese biotech and medtech companies to the list of firms posing...
Study finds RSV treatment Beyfortus prevents 5,800 hospitalisations in France
Euronews via Yahoo News· 4 days agoRoughly 5,800 hospitalisations from bronchiolitis were avoided in France thanks to the new...
Gilead gives up on $4.9B antibody as solid tumor plan unravels
FierceBiotech· 4 days agoA $4.9 billion hole has appeared in Gilead’s pipeline. After years of setbacks, the big biotech dealt a final blow to its anti-CD47 monoclonal antibody magrolimab Thursday ...
FDA grants full approval to cervical cancer drug TIVDAK By Investing.com
Investing.com· 3 hours agoNEW YORK & COPENHAGEN - Pfizer Inc. (NYSE: NYSE:PFE) and Genmab A/S (NASDAQ: NASDAQ:GMAB) have...